United Therapeutics | UTHR - Assets

Stock Price
577.78
Daily Change
-3.91 -0.67%
Monthly
7.83%
Yearly
107.17%
Q2 Forecast
547.81

United Therapeutics reported $7.88B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Amarin USD 670.78M 10.96M Dec/2025
Ardelyx USD 501.6M 15.43M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Bayer EUR 104.54B 331M Dec/2025
BioCryst Pharmaceuticals USD 514.16M 67.73M Dec/2025
Biogen USD 29.44B 232M Dec/2025
BioMarin Pharmaceutical USD 7.59B 20.85M Dec/2025
Emergent BioSolutions USD 1.82B 69.9M Dec/2023
Esperion Therapeutics USD 465.89M 101.87M Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Halozyme Therapeutics USD 2.53B 304.09M Dec/2025
Insmed USD 2.26B 96.18M Dec/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Lexicon Pharmaceuticals USD 184.99M 20.94M Dec/2025
Moderna USD 12.34B 203M Dec/2025
Omeros USD 200.57M 34.59M Jun/2025
Pfizer USD 208.73B 2.64B Sep/2025
PTC Therapeutics USD 2.9B 255.07M Dec/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sarepta Therapeutics USD 3.35B 143.73M Dec/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025
United Therapeutics USD 7.88B 528.9M Dec/2025
Vertex Pharmaceuticals USD 25.64B 780.7M Dec/2025